UAB LT Biotech is implementing the project “Production of Rapid Serological Tests”, co-financed by the European Regional Development Fund, provided under the 2014–2020. European Union Funds Investment Operational Program Priority 3 “Promotion of Small and Medium Business Competitiveness” 03.3.1-LVPA-T-859-01-0025 “COVID-19 products LT”. Funded as part of the European Union’s response to the COVID-19 pandemic.
The aim of the project is to produce products needed to combat COVID-19 (COVID-19 rapid serological tests).
Implementation of the project, it is planned to purchase and install automatic equipment for the production of rapid serological tests.
The total value of the project is EUR 192,350.00, the amount of support allocated to the project is EUR 182,732.50.